- Home
- BHVN vs CIM Comparison
BHVN vs CIM Comparison
Compare BHVN & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHVN | CIM |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BHVN | CIM |
|---|---|---|
| Price | $11.15 | $12.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $29.79 | $15.25 |
| AVG Volume (30 Days) | ★ 3.1M | 751.6K |
| Earning Date | 11-10-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 11.49% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $191,573,000.00 |
| Revenue This Year | N/A | $11.44 |
| Revenue Next Year | $1,147.70 | $21.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.48 | $9.85 |
| 52 Week High | $44.28 | $15.37 |
Technical Indicators
Market Signals| Indicator | BHVN | CIM |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 52.90 |
| Support Level | $8.50 | $12.73 |
| Resistance Level | $11.80 | $13.04 |
| Average True Range (ATR) | 0.91 | 0.24 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 81.83 | 63.47 |
Price Performance
Historical ComparisonAbout BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.